Neonatal abstinence syndrome: Historical perspective, current focus, future directions
- PMID: 26232620
- DOI: 10.1016/j.ypmed.2015.07.017
Neonatal abstinence syndrome: Historical perspective, current focus, future directions
Abstract
Background: Neonatal abstinence syndrome (NAS) occurs following prenatal opioid exposure. It is characterized by signs and symptoms indicating central nervous system hyperirritability and autonomic nervous system, gastrointestinal tract, and respiratory system dysfunction.
Objective: This article: (1) briefly reviews NAS history, including initial identification, assessment, and treatment efforts; (2) summarizes the current status of and current issues surrounding recent NAS assessment and treatment, and (3) details future directions in NAS conceptualization, measurement, and treatment.
Results: Mortality rate estimates in neonates treated for NAS exceeded 33%, and surpassed 90% for un-treated infants during the late-1800s until the mid-1900s. The focus of both assessment and treatment over the past 50years is predominantly due to two forces. First, methadone pharmacotherapy for "heroin addiction" led to women in methadone maintenance programs who were, or became pregnant. The second was defining NAS and developing a measure of neonatal withdrawal, the Neonatal Abstinence Scoring System (NASS). Various NAS treatment protocols were based on the NASS as well as other NAS measures.
Conclusions: Future research must focus on psychometrically sound screening and assessment measures of neonatal opioid withdrawal for premature, term and older infants, measuring and treating possible withdrawal from non-opioids, particularly benzodiazepines, integrated non-pharmacological treatment of NAS, weight-based versus symptom-based treatment of NAS, and second-line treatment for NAS.
Keywords: Neonatal abstinence syndrome; Neonatal opioid withdrawal; Opioid use disorder.
Copyright © 2015 Elsevier Inc. All rights reserved.
Similar articles
-
Design considerations for point-of-care clinical trials comparing methadone and buprenorphine treatment for opioid dependence in pregnancy and for neonatal abstinence syndrome.Contemp Clin Trials. 2014 Sep;39(1):158-65. doi: 10.1016/j.cct.2014.08.009. Epub 2014 Aug 23. Contemp Clin Trials. 2014. PMID: 25183042 Clinical Trial.
-
Prenatal Opioid Exposure, Neonatal Abstinence Syndrome/Neonatal Opioid Withdrawal Syndrome, and Later Child Development Research: Shortcomings and Solutions.J Addict Med. 2019 Mar/Apr;13(2):90-92. doi: 10.1097/ADM.0000000000000463. J Addict Med. 2019. PMID: 30334926
-
Psychometric assessment of the Neonatal Abstinence Scoring System and the MOTHER NAS Scale.Am J Addict. 2016 Aug;25(5):370-3. doi: 10.1111/ajad.12388. Epub 2016 Jun 11. Am J Addict. 2016. PMID: 27287965 Clinical Trial.
-
Opioid neonatal abstinence syndrome: controversies and implications for practice.Curr Drug Abuse Rev. 2014;7(1):44-58. doi: 10.2174/1874473707666141015215141. Curr Drug Abuse Rev. 2014. PMID: 25323126 Review.
-
Breastfeeding promotion for management of neonatal abstinence syndrome.J Obstet Gynecol Neonatal Nurs. 2013 Sep-Oct;42(5):517-26. doi: 10.1111/1552-6909.12242. Epub 2013 Sep 4. J Obstet Gynecol Neonatal Nurs. 2013. PMID: 24020477 Review.
Cited by
-
Letter-in-reply.J Addict Med. 2020 Jul/Aug;14(4):354-355. doi: 10.1097/ADM.0000000000000589. J Addict Med. 2020. PMID: 31972769 Free PMC article. No abstract available.
-
Treating Women Who Are Pregnant and Parenting for Opioid Use Disorder and the Concurrent Care of Their Infants and Children: Literature Review to Support National Guidance.J Addict Med. 2017 May/Jun;11(3):178-190. doi: 10.1097/ADM.0000000000000308. J Addict Med. 2017. PMID: 28406856 Free PMC article. Review.
-
Development and application of a primer and reference assessment tool for neonatal abstinence syndrome: A phase I pilot study.Contemp Clin Trials Commun. 2019 Dec 3;17:100494. doi: 10.1016/j.conctc.2019.100494. eCollection 2020 Mar. Contemp Clin Trials Commun. 2019. PMID: 31867467 Free PMC article.
-
Identification of neonatal abstinence syndrome in the community: Infants born into Canada's opioid crisis.Paediatr Child Health. 2019 May;24(2):81-84. doi: 10.1093/pch/pxy098. Epub 2018 Aug 14. Paediatr Child Health. 2019. PMID: 30996597 Free PMC article.
-
Quality Improvement Targeting Non-pharmacologic Care and As-needed Morphine Improves Outcomes in Neonatal Abstinence Syndrome.Pediatr Qual Saf. 2022 Nov 10;7(6):e612. doi: 10.1097/pq9.0000000000000612. eCollection 2022 Nov-Dec. Pediatr Qual Saf. 2022. PMID: 36382144 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous